JJJ Advisors »

Karyopharm Therapeutics shares owned by JJJ Advisors

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by JJJ Advisors from 13F filings

Historical chart of JJJ Advisors investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by JJJ Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by JJJ Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $25 17 1.53
2023-12-31 $15 17 0.88

More positions owned by JJJ Advisors

Ishares Tr Core S&p500 Etf (IVV)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr Core Us Aggbd Et (AGG)
Etf Ser Solutions Distillate Us (DSTL)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Schwab Strategic Tr Schwab Fdt Us Sc (FNDA)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)
Ishares Tr Msci Eafe Min Vl (EFAV)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Microsoft Corporation (MSFT)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Progressive Corporation (PGR)
Apple (AAPL)

View all positions for JJJ Advisors

Top funds holding Karyopharm Therapeutics

Vanguard Group
Avidity Partners Management
Palo Alto Investors
Citadel Advisors
Marshall Wace
Bnp Paribas Arbitrage, Snc
Millennium Management
CAM Group Holding A/S
Deutsche Bank Aktiengesellschaft
GSA Capital Partners
Goldman Sachs Group
Jpmorgan Chase & Co
AlphaCentric Advisors
Tejara Capital
Barclays

View all funds holding Karyopharm Therapeutics